Sylvie Mader

2.7k total citations · 1 hit paper
39 papers, 2.2k citations indexed

About

Sylvie Mader is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sylvie Mader has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Genetics and 11 papers in Oncology. Recurrent topics in Sylvie Mader's work include Estrogen and related hormone effects (22 papers), Retinoids in leukemia and cellular processes (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Sylvie Mader is often cited by papers focused on Estrogen and related hormone effects (22 papers), Retinoids in leukemia and cellular processes (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Sylvie Mader collaborates with scholars based in Canada, France and United States. Sylvie Mader's co-authors include Nahum Sonenberg, Arnim Pause, Ashkan Haghighat, John H. White, Vijay Kumar, Hubert de Verneuil, Pierre Chambon, Julie Deschênes, Nancy Bretschneider and Frank Gannon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Sylvie Mader

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E.

1995 515 citations Sylvie Mader, Nahum Sonenberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvie Mader Canada	22	1.6k	864	309	235	216	39	2.2k
Michael R. Hübner United States	9	2.2k 1.4×	1.0k 1.2×	370 1.2×	229 1.0×	163 0.8×	9	2.6k
Weijun Feng United States	20	1.5k 1.0×	1.2k 1.4×	287 0.9×	179 0.8×	183 0.8×	35	2.3k
Elisabeth Fayard France	13	1.3k 0.8×	488 0.6×	545 1.8×	217 0.9×	258 1.2×	15	2.1k
Elisabeth Scheer France	20	2.0k 1.3×	1.1k 1.3×	299 1.0×	139 0.6×	211 1.0×	30	2.5k
Martin Koš Germany	21	2.5k 1.6×	1.2k 1.4×	460 1.5×	261 1.1×	202 0.9×	32	3.1k
Christopher J. Caunt United Kingdom	25	1.5k 1.0×	303 0.4×	317 1.0×	163 0.7×	251 1.2×	40	2.3k
Christophe Rachez France	24	2.2k 1.4×	1.1k 1.2×	290 0.9×	253 1.1×	253 1.2×	35	3.1k
David L. Bain United States	22	1.5k 1.0×	1.5k 1.7×	353 1.1×	229 1.0×	307 1.4×	46	2.4k
Fred Schaufele United States	31	1.6k 1.0×	832 1.0×	225 0.7×	198 0.8×	135 0.6×	52	2.4k
Masaharu Sakai Japan	27	2.2k 1.4×	888 1.0×	371 1.2×	234 1.0×	647 3.0×	70	3.4k

Countries citing papers authored by Sylvie Mader

Since Specialization

Citations

This map shows the geographic impact of Sylvie Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Mader more than expected).

Fields of papers citing papers by Sylvie Mader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Mader. The network helps show where Sylvie Mader may publish in the future.

Co-authorship network of co-authors of Sylvie Mader

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Mader. A scholar is included among the top collaborators of Sylvie Mader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Mader. Sylvie Mader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thibault, Pierre, et al.. (2025). A short SUMOylation tag modulates transcription factor activity. Journal of Biological Chemistry. 301(11). 110807–110807.

Piva, Roberto, et al.. (2024). IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition. Cancers. 16(19). 3280–3280.

Gaboury, Louis, et al.. (2022). CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3. Cancers. 14(21). 5453–5453. 2 indexed citations

Bouvier, Michel, et al.. (2022). The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens. Journal of Biological Chemistry. 299(1). 102757–102757. 5 indexed citations

Hosfield, David J., Sandra Weber, Nan‐Sheng Li, et al.. (2022). Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. eLife. 11. 29 indexed citations

Nash, Claire, et al.. (2021). Dual-function antiandrogen/HDACi hybrids based on enzalutamide and entinostat. Bioorganic & Medicinal Chemistry Letters. 55. 128441–128441. 6 indexed citations

Mader, Sylvie, et al.. (2021). Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis. Cells. 10(11). 2966–2966. 37 indexed citations

Poirier, Donald, et al.. (2019). Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine. The Journal of Steroid Biochemistry and Molecular Biology. 191. 105352–105352. 8 indexed citations

Dumeaux, Vanessa, et al.. (2018). Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells. Oncogene. 38(7). 1019–1037. 31 indexed citations

10.

Yousef, Einas, Daniela Furrer, David Laperrière, et al.. (2017). MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation. Modern Pathology. 30(5). 682–697. 64 indexed citations

11.

Cavallone, Luca, Aline Mamo, Catherine Chabot, et al.. (2015). The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Research. 75(20). 4351–4363. 41 indexed citations

12.

Stambouli, Nejla, Houssein Khodjet‐El‐Khil, Nancy Uhrhammer, et al.. (2014). Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases’ occurrence. Medical Oncology. 31(11). 255–255. 12 indexed citations

13.

Nguyen, David H., Virginie Dupont, Jean Deschênes, et al.. (2007). Rational design of an estrogen receptor mutant with altered DNA-binding specificity. Nucleic Acids Research. 35(10). 3465–3477. 8 indexed citations

14.

Dayan, Guila, Mathieu Lupien, Anick Auger, et al.. (2006). Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α. Molecular Pharmacology. 70(2). 579–588. 29 indexed citations

15.

Rocha, Walter, Rocío Sánchez, Julie Deschênes, et al.. (2005). Opposite Effects of Histone Deacetylase Inhibitors on Glucocorticoid and Estrogen Signaling in Human Endometrial Ishikawa Cells. Molecular Pharmacology. 68(6). 1852–1862. 15 indexed citations

16.

Bourdeau, Véronique, Julie Deschênes, Raphaël Métivier, et al.. (2004). Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse. Molecular Endocrinology. 18(6). 1411–1427. 274 indexed citations

17.

Rousseau, Caroline, Filippa Pettersson, Marie-Claude Couture, et al.. (2003). The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 86(1). 1–14. 34 indexed citations

18.

Anghel, Silvia I., et al.. (2000). Aspartate 351 of Estrogen Receptor α Is Not Crucial for the Antagonist Activity of Antiestrogens. Journal of Biological Chemistry. 275(27). 20867–20872. 26 indexed citations

19.

Mader, Sylvie & Nahum Sonenberg. (1995). Cap binding complexes and cellular growth control. Biochimie. 77(1-2). 40–44. 31 indexed citations

20.

White, John H., K McCuaig, & Sylvie Mader. (1994). A Simple and Sensitive High–Throughput Assay for Steroid Agonists and Antagonists. Bio/Technology. 12(10). 1003–1007. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact